U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula 2C19H21FN2O2.C4H4O4
Molecular Weight 772.8334
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 5
Charge 0

SHOW SMILES / InChI
Structure of EPLIVANSERIN FUMARATE

SMILES

OC(=O)\C=C\C(O)=O.CN(C)CCO\N=C(\C=C\C1=CC=C(O)C=C1)C2=C(F)C=CC=C2.CN(C)CCO\N=C(\C=C\C3=CC=C(O)C=C3)C4=C(F)C=CC=C4

InChI

InChIKey=RNLKLYQQDLHHBH-ABDBJYMXSA-N
InChI=1S/2C19H21FN2O2.C4H4O4/c2*1-22(2)13-14-24-21-19(17-5-3-4-6-18(17)20)12-9-15-7-10-16(23)11-8-15;5-3(6)1-2-4(7)8/h2*3-12,23H,13-14H2,1-2H3;1-2H,(H,5,6)(H,7,8)/b2*12-9+,21-19-;2-1+

HIDE SMILES / InChI

Molecular Formula C4H4O4
Molecular Weight 116.0722
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 1
Optical Activity NONE

Molecular Formula C19H21FN2O2
Molecular Weight 328.3806
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 2
Optical Activity NONE

Eplivanserin (SR 46349) is an antagonist of serotonin 2A receptor. Eplivanserin was previously in development by Sanofi-aventis in an effort to educate the public regarding this new mechanism of action for sleep aids. Eplivanserin was reviewed by the FDA as a potential treatment for patients with chronic insomnia, but the FDA requested additional information regarding benefit-risk and development of the drug has been discontinued.

Approval Year

Targets
PubMed

PubMed

TitleDatePubMed
Patents

Patents

Sample Use Guides

Phase III study: 5 mg/day for 12 weeks
Route of Administration: Oral
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:41:52 GMT 2023
Edited
by admin
on Fri Dec 15 15:41:52 GMT 2023
Record UNII
BT8UYC46KA
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
EPLIVANSERIN FUMARATE
USAN  
USAN  
Official Name English
EPLIVANSERIN HEMIFUMARATE
DASH  
Common Name English
SR46349B
Code English
(1Z,2E)-1-(2-FLUOROPHENYL)-3-(4-HYDROXYPHENYL)PROP-2-EN-1-ONE O-(2-(DIMETHYLAMINO)ETHYL)OXIME (2E)-BUT-2-ENEDIOATE (2:1) (SALT)
Systematic Name English
EPLIVANSERIN FUMARATE [USAN]
Common Name English
SR-46349B
Code English
(4-((1E,3Z)-3-((2-(DIMETHYLAMINO)ETHOXY)IMINO)-3-(2-FLUOROPHENYL)PROP-1- ENYL)PHENOL)(2E)-2-BUTENEDIOATE (2:1)
Systematic Name English
2-PROPEN-1-ONE, 1-(2-FLUOROPHENYL)-3-(4-HYDROXYPHENYL)-, O-(2- (DIMETHYLAMINO)ETHYL)OXIME, (1Z,2E)-, (2E)-2-BUTENEDIOATE (2:1)
Systematic Name English
Classification Tree Code System Code
NCI_THESAURUS C66885
Created by admin on Fri Dec 15 15:41:52 GMT 2023 , Edited by admin on Fri Dec 15 15:41:52 GMT 2023
Code System Code Type Description
EVMPD
SUB30302
Created by admin on Fri Dec 15 15:41:52 GMT 2023 , Edited by admin on Fri Dec 15 15:41:52 GMT 2023
PRIMARY
ChEMBL
CHEMBL257704
Created by admin on Fri Dec 15 15:41:52 GMT 2023 , Edited by admin on Fri Dec 15 15:41:52 GMT 2023
PRIMARY
USAN
WW-97
Created by admin on Fri Dec 15 15:41:52 GMT 2023 , Edited by admin on Fri Dec 15 15:41:52 GMT 2023
PRIMARY
FDA UNII
BT8UYC46KA
Created by admin on Fri Dec 15 15:41:52 GMT 2023 , Edited by admin on Fri Dec 15 15:41:52 GMT 2023
PRIMARY
CAS
130580-02-8
Created by admin on Fri Dec 15 15:41:52 GMT 2023 , Edited by admin on Fri Dec 15 15:41:52 GMT 2023
PRIMARY
EPA CompTox
DTXSID201033898
Created by admin on Fri Dec 15 15:41:52 GMT 2023 , Edited by admin on Fri Dec 15 15:41:52 GMT 2023
PRIMARY
PUBCHEM
135456189
Created by admin on Fri Dec 15 15:41:52 GMT 2023 , Edited by admin on Fri Dec 15 15:41:52 GMT 2023
PRIMARY
NCI_THESAURUS
C95215
Created by admin on Fri Dec 15 15:41:52 GMT 2023 , Edited by admin on Fri Dec 15 15:41:52 GMT 2023
PRIMARY
SMS_ID
100000092728
Created by admin on Fri Dec 15 15:41:52 GMT 2023 , Edited by admin on Fri Dec 15 15:41:52 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY